title: Successful treatment of acute Epstein-Barr virus infection associated with X-linked lymphoproliferative disorder with rituximab.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Bond
authors.forename: Raveen
authors.initials: R
authors.lastname: Shahdadpuri
authors.forename: Corrina
authors.initials: C
authors.lastname: Mc Mahon
authors.forename: Aengus
authors.initials: A
authors.lastname: O'marcaigh
authors.forename: Melanie
authors.initials: M
authors.lastname: Cotter
authors.forename: Owen
authors.initials: O
authors.lastname: Smith
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D004359:Drug Therapy, Combination; D020031:Epstein-Barr Virus Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000821:virology; D008297:Male; D000069283:Rituximab; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab